antipyrine has been researched along with galactose in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (64.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freides, D; Jenko, P; Rikkers, L; Rudman, D | 1 |
| Breimer, DD; Richter, E; Zilly, W | 1 |
| Breimer, DD; Buchenau, D; Richter, E; Wernze, H; Zilly, W | 1 |
| Andreasen, PB; Greisen, G | 1 |
| Bonkovsky, HL; Fiellin, DA; Galambos, JT; Simon, D; Slaker, DP; Smith, GS | 1 |
| Fischer-Nielsen, A; Hage, E; Hansen, BA; Keiding, S; Poulsen, HE | 1 |
| Dodson, TF; Galloway, JR; Henderson, JM; Jennings, H; Kawasaki, S; Marsh, JW; Millikan, WJ; Perlino, CA; Stewart, MT; Warren, WD | 1 |
| Morgan, DV; Smallwood, RA | 1 |
| Fischer-Nielsen, A; Hansen, BA; Keiding, S; Poulsen, HE; Tygstrup, N | 1 |
| Beppu, T; Hanano, M; Idezuki, Y; Iga, T; Kawasaki, S; Sanjo, K; Sugiura, M; Sugiyama, Y | 1 |
| Adel Hansen, B; Enghusen Poulsen, H | 1 |
| Hansen, BA; Poulsen, HE | 1 |
| Poulsen, HE; Thomsen, HK; Tvedegaard, E; Vilstrup, H | 1 |
| Andreasen, PB; Ranek, L; Statland, BE; Tygstrup, N | 1 |
| Tygstrup, N; Vilstrup, H | 1 |
| Bircher, J | 1 |
| Andreasen, PB; Bahnsen, M; Bremmelgaard, A; Christensen, E; Ranek, L | 1 |
| Andreasen, PB; Ramsøe, K; Ranek, L | 1 |
| Bacci, G; Fabbri, A; Ferrari, S; Figus, E; Longhi, C; Marchesini, G; Marchi, E; Motta, E | 1 |
| Dixon, R; Frye, RF; Matzke, GR; Rabinovitz, M; Schade, R | 1 |
| Baker, AB; Gao, L; Ramzan, I | 1 |
| Christiansen, JS; Gravholt, CH; Ott, P; Poulsen, HE; Vilstrup, H | 1 |
| Lü, Y; Pan, ZJ; Qiu, XM; Tian, LM; Yang, XB | 1 |
| Fu, D; O'Neill, RA | 1 |
| Arai, A; Honda, S; Ishida, Y; Nakanishi, H; Suzuki, S | 1 |
3 review(s) available for antipyrine and galactose
| Article | Year |
|---|---|
Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation of the hepatocyte.
Topics: Aminopyrine; Ammonia; Antipyrine; Bile Acids and Salts; Bilirubin; Galactose; Humans; Liver Diseases; Liver Function Tests; Prothrombin Time; Serum Albumin; Sulfobromophthalein; Urea | 1983 |
Quantitative assessment of deranged hepatic function: a missed opportunity?
Topics: Adult; Aminopyrine; Antipyrine; Blood Circulation; Breath Tests; Chronic Disease; Galactose; Humans; Liver; Liver Circulation; Liver Diseases; Liver Function Tests; Male; Portal System; Sulfobromophthalein | 1983 |
Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery.
Topics: Adult; Antipyrine; Biomarkers; Breath Tests; Caffeine; Coloring Agents; Galactose; Humans; Indocyanine Green; Lidocaine; Liver; Liver Function Tests; Liver Transplantation; Postoperative Period; Reference Values | 2000 |
2 trial(s) available for antipyrine and galactose
| Article | Year |
|---|---|
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function.
Topics: Adult; Analysis of Variance; Antipyrine; Cardiac Output; Combined Modality Therapy; Female; Galactose; Hepatitis, Alcoholic; Humans; Liver; Liver Circulation; Male; Middle Aged; Oxandrolone; Parenteral Nutrition; Time Factors | 1991 |
Quantitative liver functions in Turner syndrome with and without hormone replacement therapy.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Body Composition; Calorimetry, Indirect; Coloring Agents; Cross-Over Studies; Estradiol; Female; Galactose; gamma-Glutamyltransferase; Hormone Replacement Therapy; Humans; Indocyanine Green; Liver; Liver Function Tests; Nitrogen; Progestins; Turner Syndrome | 2007 |
20 other study(ies) available for antipyrine and galactose
| Article | Year |
|---|---|
Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism.
Topics: Ammonia; Antipyrine; Electroencephalography; Fatty Liver, Alcoholic; Female; Galactose; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Neurologic Examination; Nitrogen; Portacaval Shunt, Surgical | 1978 |
Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
Topics: Adult; Antipyrine; Galactose; Half-Life; Hexobarbital; Humans; Indocyanine Green; Male; Metabolic Clearance Rate; Rifampin | 1977 |
[Influence of rifampicin on the metabolic clearance of galactose and antipyrine as compared with hexobarbital].
Topics: Adult; Antipyrine; Galactose; Hexobarbital; Humans; Liver; Metabolic Clearance Rate; Rifampin; Stimulation, Chemical | 1975 |
Phenazone metabolism in patients with liver disease.
Topics: Adult; Aged; Antipyrine; Creatinine; Galactose; Humans; Injections, Intravenous; Kinetics; Liver Diseases; Liver Function Tests; Male; Middle Aged | 1976 |
CCl4 cirrhosis in rats: irreversible histological changes and differentiated functional impairment.
Topics: Animals; Antipyrine; Carbon Tetrachloride; Galactose; Liver; Liver Cirrhosis, Experimental; Male; Phenobarbital; Rats; Rats, Inbred Strains; Urea | 1991 |
Change in hepatic function, hemodynamics, and morphology after liver transplant. Physiological effect of therapy.
Topics: Adult; Amino Acids; Antipyrine; Bilirubin; Biopsy; Costs and Cost Analysis; Female; Follow-Up Studies; Galactose; Humans; Liver; Liver Circulation; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mortality; Prothrombin Time; Sclerosing Solutions; Serum Albumin; Splenorenal Shunt, Surgical | 1989 |
Hepatic drug clearance in chronic liver disease: can we expect to find a universal, quantitative marker of hepatic function?
Topics: Antipyrine; Biomarkers; Galactose; Humans; Indocyanine Green; Liver Circulation; Liver Cirrhosis; Liver Function Tests; Metabolic Clearance Rate | 1989 |
Age dependence of rat liver function measurements.
Topics: Aging; Animals; Antipyrine; Cytochrome P-450 Enzyme System; Galactose; Glutathione; Liver; Male; Rats; Rats, Inbred Strains; Urea; Xenobiotics | 1989 |
Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases.
Topics: Adult; Aged; Antipyrine; Chronic Disease; Female; Galactose; Galactosemias; Hepatitis; Humans; Indocyanine Green; Liver; Liver Circulation; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Models, Biological | 1988 |
Changes in the hepatic capacity of urea-N synthesis, galactose elimination and antipyrine clearance following 70% hepatectomy in the rat.
Topics: Animals; Antipyrine; Female; Galactose; Hepatectomy; Insulin; Liver; Organ Size; Rats; Rats, Inbred Strains; Regeneration; Urea | 1986 |
The capacity of urea-N synthesis as a quantitative measure of the liver mass in rats.
Topics: Animals; Antipyrine; Female; Galactose; Liver; Metabolic Clearance Rate; Nitrogen; Rats; Rats, Inbred Strains; Urea | 1986 |
Functional status of the liver during chronic renal failure: an experimental study in the rabbit.
Topics: Animals; Antipyrine; Body Weight; Edetic Acid; Galactose; Kidney Failure, Chronic; Liver; Male; Metabolic Clearance Rate; Nephrectomy; Rabbits | 1985 |
Clearance of antipyrine-dependence of quantitative liver function.
Topics: Adult; Antipyrine; Female; Galactose; Humans; Liver; Liver Diseases; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Prothrombin; Serum Albumin; Time Factors | 1974 |
Cholic acid conjugation test and quantitative liver function in acute liver failure.
Topics: Acute Disease; Antipyrine; Chemical and Drug Induced Liver Injury; Cholic Acids; Diagnosis, Differential; Evaluation Studies as Topic; Female; Galactose; Glycocholic Acid; Hepatic Encephalopathy; Hepatitis, Viral, Human; Humans; Liver Function Tests; Male; Prognosis | 1983 |
Functioning liver mass in uncomplicated and fulminant acute hepatitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Alanine Transaminase; Antipyrine; Bilirubin; Chemical and Drug Induced Liver Injury; Female; Galactose; Galactosemias; Hepatitis, Viral, Human; Humans; Liver Function Tests; Male; Middle Aged; Prognosis | 1980 |
High-dose methotrexate treatment and liver function in patients with osteosarcoma.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Antipyrine; Bone Neoplasms; Cisplatin; Doxorubicin; Female; Galactose; Humans; Liver; Liver Function Tests; Male; Methotrexate; Osteosarcoma; Prospective Studies | 1994 |
Effects of liver disease on the disposition of the opioid antagonist nalmefene.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Case-Control Studies; Female; Galactose; Glucuronates; Humans; Injections, Intravenous; Liver Diseases; Male; Matched-Pair Analysis; Middle Aged; Naltrexone; Narcotic Antagonists; Severity of Illness Index | 1997 |
[Development of a new HPLC technique for analyzing monosaccharide composition and its application in the quality control of Silybum marianum polysaccharide].
Topics: Antipyrine; Arabinose; Chromatography, High Pressure Liquid; Edaravone; Galactose; Glucose; Glucuronic Acid; Hexuronic Acids; Mannose; Monosaccharides; Plants, Medicinal; Polysaccharides; Quality Control; Rhamnose; Seeds; Silybum marianum; Spectrophotometry, Ultraviolet; Xylose | 2010 |
Monosaccharide composition analysis of oligosaccharides and glycoproteins by high-performance liquid chromatography.
Topics: Antipyrine; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Edaravone; Glycoproteins; Hexosamines; Hexoses; Hydrolysis; Monosaccharides; Oligosaccharides; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Sialic Acids; Time Factors | 1995 |
High-speed electrophoretic analysis of 1-phenyl-3-methyl-5-pyrazolone derivatives of monosaccharides on a quartz microchip with whole-channel UV detection.
Topics: alpha-Amylases; Antipyrine; Edaravone; Electrophoresis, Capillary; Free Radical Scavengers; Hexoses; Indicators and Reagents; Monosaccharides; Oligosaccharides; Pentoses; Reproducibility of Results | 2003 |